Fatigue complicating chronic liver disease.

Area of Science:

• Hepatology
• Neuroscience
• Pharmacology

Background:

• Profound fatigue is a prevalent and debilitating symptom in patients with chronic liver diseases, including primary biliary cirrhosis (PBC) and chronic hepatitis C.
• The exact causes of fatigue in these patients remain unclear, with potential links to viral infection, cholestasis, psychological factors, or the underlying liver disease itself.
• Evaluating fatigue treatments is challenging due to its subjective nature and the lack of objective efficacy endpoints in clinical trials.

Purpose of the Study:

• To investigate the potential of ondansetron, a 5-HT3 serotonin receptor antagonist, in ameliorating profound fatigue in patients with chronic liver disease.
• To explore the role of the serotonin neurotransmitter system in central fatigue, drawing from experimental studies.

Main Methods:

• Review of experimental studies implicating the serotonin system in central fatigue.
• Clinical observation of ondansetron administration in patients with chronic liver disease experiencing profound fatigue.

Main Results:

• Experimental studies suggest the serotonin system is involved in central fatigue.
• Administration of ondansetron was associated with significant and sustained improvement in profound fatigue in some patients with chronic liver disease.

Conclusions:

• Ondansetron shows promise as a treatment for profound fatigue in chronic liver disease patients.
• Targeting the serotonin system may offer a novel therapeutic approach for managing fatigue in hepatology.